Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

IO Biotech has finished enrolling subjects in a Phase II trial of IO102-IO103 in conjunction with MSD's KEYTRUDA (pembrolizumab).

Bollywood Star Saif Ali Khan was reportedly stabbed multiple times during a home invasion at his property in Mumbai on ...

A state appeals court panel Tuesday upheld an Inglewood man’s conviction for fatally stabbing a woman he had briefly dated ...

An Orange County Superior Court judge Friday praised a proposed $233 million settlement with Disney in a class action suit stemming from a dispute over Anaheim’s minimum wage law and could be on track ...

Johnson & Johnson (J&J) has reported positive topline outcomes from the Phase III MARIPOSA trial of Rybrevant ...

The poll released on Monday, sponsored by North Dakota United, an education and public employee union, showed 81% of ...

The president ordered the withdrawal of the country from the Paris climate agreement and took action on immigration policy ...

With clinical trials facing multiple challenges, digital solutions could provide the answer. We identify the key trends to ...

Getty and Shutterstock merge to combat industry decline, but there are hurdles that the combined company will need to clear.